特比萘芬耐药鼻癣1例。

Q3 Medicine
Case Reports in Dermatological Medicine Pub Date : 2021-11-29 eCollection Date: 2021-01-01 DOI:10.1155/2021/9611072
Alireza Firooz, Ensieh Lotfali, Mahsa Fattahi, Maryam Fattahi, Akram Miramin Mohammadi, Mahshid Shahrzad Kavkani
{"title":"特比萘芬耐药鼻癣1例。","authors":"Alireza Firooz,&nbsp;Ensieh Lotfali,&nbsp;Mahsa Fattahi,&nbsp;Maryam Fattahi,&nbsp;Akram Miramin Mohammadi,&nbsp;Mahshid Shahrzad Kavkani","doi":"10.1155/2021/9611072","DOIUrl":null,"url":null,"abstract":"<p><p>A 26-year-old male patient referred to our center with a history of extremely itchy crusted skin lesions in his groins for one year. Moreover, his friend, a 25-year-old male, also developed similar lesions in the groin after using the shared pool, whose condition also did not improve with similar treatment. A regular mycology test (direct and culture test) was performed, as well as molecular examination. The antifungal susceptibility assay to terbinafine, itraconazole, posaconazole, fluconazole, and voriconazole was conducted according to the Clinical and Laboratory Standards Institute M38 third ed. The sequencing study identified <i>T. tonsurans</i> as the causative organism in both patients. The abovementioned organism isolated from both patients displayed resistance against terbinafine and fluconazole (MIC ≥ 4 <i>µ</i>g/ml and MIC ≥ 8 <i>µ</i>g/ml, respectively). Moreover, the susceptibility of both subjects to posaconazole (0.313 <i>µ</i>g/ml), voriconazole (0.25-0.0625 <i>µ</i>g/ml), and (1 <i>µ</i>g/ml) itraconazole increased. The present report aimed to emphasize the increase in antifungal resistance and a demand for antifungal stewardship, to control this public health threat.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2021 ","pages":"9611072"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677411/pdf/","citationCount":"2","resultStr":"{\"title\":\"A Case of Terbinafine-Resistant Tinea Cruris Caused by <i>Trichophyton tonsurans</i>.\",\"authors\":\"Alireza Firooz,&nbsp;Ensieh Lotfali,&nbsp;Mahsa Fattahi,&nbsp;Maryam Fattahi,&nbsp;Akram Miramin Mohammadi,&nbsp;Mahshid Shahrzad Kavkani\",\"doi\":\"10.1155/2021/9611072\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A 26-year-old male patient referred to our center with a history of extremely itchy crusted skin lesions in his groins for one year. Moreover, his friend, a 25-year-old male, also developed similar lesions in the groin after using the shared pool, whose condition also did not improve with similar treatment. A regular mycology test (direct and culture test) was performed, as well as molecular examination. The antifungal susceptibility assay to terbinafine, itraconazole, posaconazole, fluconazole, and voriconazole was conducted according to the Clinical and Laboratory Standards Institute M38 third ed. The sequencing study identified <i>T. tonsurans</i> as the causative organism in both patients. The abovementioned organism isolated from both patients displayed resistance against terbinafine and fluconazole (MIC ≥ 4 <i>µ</i>g/ml and MIC ≥ 8 <i>µ</i>g/ml, respectively). Moreover, the susceptibility of both subjects to posaconazole (0.313 <i>µ</i>g/ml), voriconazole (0.25-0.0625 <i>µ</i>g/ml), and (1 <i>µ</i>g/ml) itraconazole increased. The present report aimed to emphasize the increase in antifungal resistance and a demand for antifungal stewardship, to control this public health threat.</p>\",\"PeriodicalId\":9630,\"journal\":{\"name\":\"Case Reports in Dermatological Medicine\",\"volume\":\"2021 \",\"pages\":\"9611072\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677411/pdf/\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Dermatological Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2021/9611072\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Dermatological Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/9611072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

摘要

一位26岁的男性患者因其腹股沟极痒结痂皮损病史转介至本中心一年。此外,他的朋友,一名25岁的男性,在使用共享泳池后也出现了类似的腹股沟病变,同样的治疗也没有改善。进行常规真菌学试验(直接试验和培养试验),以及分子检查。对特比萘芬、伊曲康唑、泊沙康唑、氟康唑和伏立康唑进行抗真菌药敏试验,按照临床与实验室标准协会M38第三版进行。测序研究确定两例患者的病原菌为T. tonsurans。从两例患者中分离出的上述微生物对特比萘芬和氟康唑均表现出耐药性(MIC分别≥4µg/ml和MIC≥8µg/ml)。此外,两组受试者对泊沙康唑(0.313µg/ml)、伏立康唑(0.25 ~ 0.0625µg/ml)和伊曲康唑(1µg/ml)的敏感性均增加。本报告旨在强调抗真菌耐药性的增加和对抗真菌管理的需求,以控制这一公共卫生威胁。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

A Case of Terbinafine-Resistant Tinea Cruris Caused by <i>Trichophyton tonsurans</i>.

A Case of Terbinafine-Resistant Tinea Cruris Caused by Trichophyton tonsurans.

A 26-year-old male patient referred to our center with a history of extremely itchy crusted skin lesions in his groins for one year. Moreover, his friend, a 25-year-old male, also developed similar lesions in the groin after using the shared pool, whose condition also did not improve with similar treatment. A regular mycology test (direct and culture test) was performed, as well as molecular examination. The antifungal susceptibility assay to terbinafine, itraconazole, posaconazole, fluconazole, and voriconazole was conducted according to the Clinical and Laboratory Standards Institute M38 third ed. The sequencing study identified T. tonsurans as the causative organism in both patients. The abovementioned organism isolated from both patients displayed resistance against terbinafine and fluconazole (MIC ≥ 4 µg/ml and MIC ≥ 8 µg/ml, respectively). Moreover, the susceptibility of both subjects to posaconazole (0.313 µg/ml), voriconazole (0.25-0.0625 µg/ml), and (1 µg/ml) itraconazole increased. The present report aimed to emphasize the increase in antifungal resistance and a demand for antifungal stewardship, to control this public health threat.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
24
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信